These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30430204)

  • 1. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
    Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
    Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
    Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
    Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
    Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 Macrophage Polarization Prevails in Epstein-Barr Virus-Infected Children in an Immunoregulatory Environment.
    Moyano A; Ferressini Gerpe NM; De Matteo E; Preciado MV; Chabay P
    J Virol; 2022 Jan; 96(1):e0143421. PubMed ID: 34643432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion.
    Chen Y; Ouyang D; Wang Y; Pan Q; Zhao J; Chen H; Yang X; Tang Y; Wang Q; Li Y; He J; You JQ; Li Y; Xu C; Ren Y; Xie S; Li S; Lian J; Weng D; Xiang T; Xia JC
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38886114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma.
    Carreras J; Kikuti YY; Hiraiwa S; Miyaoka M; Tomita S; Ikoma H; Ito A; Kondo Y; Itoh J; Roncador G; Martinez A; Colomo L; Hamoudi R; Ando K; Nakamura N
    Cancer Sci; 2022 Jan; 113(1):334-348. PubMed ID: 34706126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) provides survival factors to EBV
    Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
    Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
    Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
    Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
    Keane C; Tobin J; Gunawardana J; Francis S; Gifford G; Gabrielli S; Gill A; Stevenson W; Talaulikar D; Gould C; Jain S; Birch S; Hertzberg M; Gandhi MK
    Eur J Haematol; 2019 Sep; 103(3):200-207. PubMed ID: 31211907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
    Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
    Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
    Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
    Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of co-inhibitory molecules B7-H4 and B7-H1 in Epstein-Barr virus positive diffuse large B-cell lymphoma and their roles in tumor invasion.
    Jiang Y; Lin J; Zhang J; Lu S; Wang C; Tong Y
    Pathol Res Pract; 2019 Dec; 215(12):152684. PubMed ID: 31679792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.
    Wang J; Gao K; Lei W; Dong L; Xuan Q; Feng M; Wang J; Ye X; Jin T; Zhang Z; Zhang Q
    Oncotarget; 2017 Jan; 8(3):5414-5425. PubMed ID: 28036275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.
    Parkhi M; Chatterjee D; Bal A; Vias P; Yadav BS; Prakash G; Gupta SK; Radotra BD
    APMIS; 2022 Feb; 130(2):82-94. PubMed ID: 34862664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.